Example: Heart Attack

Search clinical trials for: Docetaxel

Total 2360 results

NCT04563975

Recruiting

Efficacy and Safty of Toripalimab Combined With Docetaxel in Patients With Advanced Gastric Cancer

Conditions: Gastric Cancer Stage IV
NCT04565600

Recruiting

Etoricoxib for Prevention of Musculoskeletal Pain in Patients With Early-Stage Breast Cancer Receiving Docetaxel Chemotherapy and Pegfilgrastim

Conditions: Musculoskeletal Pain
NCT04547153

Not yet recruiting

LD-FUD for Highly Aggressive Gastric Cancer

Conditions: Gastric Cancer; Bone Marrow Metastasis; Thrombocytopenia
NCT04547907

Recruiting

Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer, A Multicenter, Randomized, Phase III Clinical Trial

Conditions: Breast Cancer,Her2 Positive
NCT04545632

Recruiting

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor

Conditions: Breast Cancer; NSCLC; Prostate Cancer; Head and Neck Cancer; Gastric Cancer; Esophageal Cancer; Ovarian Cancer
NCT04543175

Completed

Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.

Conditions: Breast Cancer; Taste Disorders; Dysgeusia; Ageusia; Quality of Life
NCT04544969

Recruiting

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Conditions: Circulating Tumor Cell; Nasopharyngeal Carcinoma; Distant Metastases.Clinical; Effects of Chemotherapy
NCT04540692

Not yet recruiting

Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer

Conditions: Breast Cancer
NCT04538833

Recruiting

Monosialic Gangliosides to Treat Paclitaxel / Docetaxel Neurotoxicity

Conditions: Early Breast Cancer
NCT04535713

Not yet recruiting

Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma

Conditions: Sarcoma
NCT04533958

Not yet recruiting

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

Conditions: Metastatic Prostate Cancer
NCT04527991

Not yet recruiting

Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer

Conditions: Urothelial Carcinoma; Bladder Cancer; Metastatic Urothelial Carcinoma; Locally Advanced Urothelial Cancer; Transitional Cell Carcinoma
NCT04526782

Not yet recruiting

ENCOrafenib With Binimetinib in bRAF NSCLC

Conditions: Non Small Cell Lung Cancer; BRAF V600E
NCT04522011

Not yet recruiting

Comparison of the Efficiency Between Intraoperative and Postoperative Hyperthermic Intraperitoneal Chemotherapy With Docetaxel Combine Oxaliplatin in Patients With Advanced Gastric Cancer

Conditions: Stomach Neoplasms; Hyperthermic Intraperitoneal Chemotherapy
NCT04522336

Not yet recruiting

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Conditions: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; Localized Gastroesophageal Junction Adenocarcinoma; Locally Advanced Gastroesophageal Junction Adenocarcinoma; Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8; Unresectable Gastroesophageal Junction Adenocarcinoma
NCT04514419

Recruiting

Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel

Conditions: Breast Cancer
NCT04515602

Not yet recruiting

Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma
NCT04508816

Recruiting

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC With Induced Chemotherapy Resistance

Conditions: Nasopharyngeal Carcinoma
NCT04508829

Recruiting

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC With Induced Chemotherapy Resistance

Conditions: Oropharyngeal Carcinoma
NCT04502641

Recruiting

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

Conditions: Hypopharyngeal Cancer
NCT04499118

Not yet recruiting

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Conditions: HER2-negative Breast Cancer
NCT04495179

Not yet recruiting

A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Conditions: Progressive Metastatic Castrate-Resistant Prostate Cancer
NCT04491084

Not yet recruiting

FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy

Conditions: Non Small Cell Lung Cancer; Lung Cancer
NCT04471428

Recruiting

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

Conditions: Carcinoma, Non-Small-Cell Lung
NCT04471675

Not yet recruiting

Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel

Conditions: Advanced Solid Tumors
NCT04472403

Recruiting

Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma

Conditions: Nasopharyngeal Carcinoma; Metastasis; Chemotherapy; Survival
NCT04467801

Not yet recruiting

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy

Conditions: NSCLC Stage IV; NSCLC Stage IIIB
NCT04447118

Not yet recruiting

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Conditions: Non-squamous NSCLC; HER2 Exon 20 Mutation
NCT04447352

Not yet recruiting

HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)

Conditions: Gastric Cancer; Gastroesophageal Junction Adenocarcinoma
NCT04437329

Recruiting

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Conditions: Nasopharyngeal Carcinoma
NCT04430933

Not yet recruiting

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Conditions: Advanced or Metastatic Solid Tumors; Non-Small Cell Lung Cancer
NCT04427072

Recruiting

Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

Conditions: Carcinoma, Non-Small-Cell Lung
NCT04428151

Recruiting

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

Conditions: Squamous Cell Carcinoma of Head and Neck
NCT04419181

Not yet recruiting

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Conditions: HER2-positive Breast Cancer
NCT04414566

Not yet recruiting

Induction Chemotherapy Plus Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Conditions: Nasopharyngeal Carcinoma
NCT04413227

Recruiting

A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors

Conditions: NSCLC; Solid Tumor
NCT04410887

Not yet recruiting

Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)

Conditions: Stomach Cancer; Gastric Cancer
NCT04404140

Recruiting

A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Conditions: Castration-Resistant Prostatic Cancer
NCT04399876

Recruiting

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

Conditions: Prostate Cancer; Radical Prostatectomy
NCT04400695

Not yet recruiting

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Conditions: Breast Cancer
NCT04397341

Completed

Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck

Conditions: Locally Advanced Head and Neck Carcinoma
NCT04396535

Not yet recruiting

Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer

Conditions: Advanced Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8
NCT04393584

Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

Conditions: Stomach Neoplasms; Gastrointestinal Neoplasms; Docetaxel; Oxaliplatin; Fluoruracil; Irinotecan Hydrochloride
NCT04385550

Not yet recruiting

A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma

Conditions: Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma
NCT04385563

Recruiting

A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.

Conditions: HER2-positive Metastatic Breast Cancer
NCT04386746

Recruiting

Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer

Conditions: Urothelial Carcinoma Bladder; Bladder Cancer
NCT04384601

Not yet recruiting

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

Conditions: Gastric Cancer; Neoadjuvant Chemotherapy
NCT04381832

Recruiting

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Conditions: Prostatic Neoplasms, Castration-Resistant; Androgen-Resistant Prostatic Neoplasms; Castration Resistant Prostatic Neoplasms; Prostatic Cancer, Castration-Resistant
NCT04375605

Recruiting

Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ

Conditions: Gastroesophageal Junction Adenocarcinoma
NCT04367090

Not yet recruiting

Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer

COOKIE SETTINGS

Search clinical trials for: Docetaxel